CIK 0001645460 · Non-accelerated filer<br>Smaller reporting company
Cue Biopharma, Inc.
Sign in to watch- Ticker
- CUE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473324577
- Phone
- 617-949-2680
- Business address
- 100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
- Former names
- Imagen Biopharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $389,304
- in 3 filings
Net −$389,304. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 20 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-23 | Millar Kerri-Ann CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −6,667 | 6,667 | ||
| 2021-03-16 | Pienta Kenneth Chief Medical Officer | Option exercise | +439 | $5.00 | $2K | 2,439 |
| 2021-03-16 | Pienta Kenneth Chief Medical Officer | Sale | −439 | $15.09 | $7K | 2,000 |
| 2021-03-16 | Pienta Kenneth Chief Medical Officer | Option exercise · Stock Option (right to buy) | −439 | 133,567 | ||
| 2021-03-15 | Pienta Kenneth Chief Medical Officer | Option exercise | +13,000 | $5.00 | $65K | 15,000 |
| 2021-03-15 | Pienta Kenneth Chief Medical Officer | Sale | −13,000 | $15.10 | $196K | 2,000 |
| 2021-03-15 | Pienta Kenneth Chief Medical Officer | Option exercise · Stock Option (right to buy) | −13,000 | 134,006 | ||
| 2021-02-17 | Pienta Kenneth Chief Medical Officer | Option exercise | +1,280 | $2.86 | $4K | 3,280 |
| 2021-02-17 | Pienta Kenneth Chief Medical Officer | Option exercise | +2,994 | $5.00 | $15K | 6,274 |
| 2021-02-17 | Pienta Kenneth Chief Medical Officer | Sale | −4,274 | $15.06 | $64K | 2,000 |
| 2021-02-17 | Pienta Kenneth Chief Medical Officer | Option exercise · Stock Option (right to buy) | −1,280 | 0 | ||
| 2021-02-17 | Pienta Kenneth Chief Medical Officer | Option exercise · Stock Option (right to buy) | −2,994 | 147,006 | ||
| 2021-02-16 | Pienta Kenneth Chief Medical Officer | Option exercise | +16,000 | $2.86 | $46K | 18,000 |
| 2021-02-16 | Pienta Kenneth Chief Medical Officer | Sale | −16,000 | $15.15 | $242K | 2,000 |
| 2021-02-16 | Pienta Kenneth Chief Medical Officer | Option exercise · Stock Option (right to buy) | −16,000 | 1,280 | ||
| 2021-02-10 | Pienta Kenneth Chief Medical Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-02-10 | Suri Anish President and CSO | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2021-02-10 | PASSERI DANIEL R CEO | Grant or award · Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2021-02-10 | Sandercock Colin SVP, General Counsel and Sec | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-02-10 | Millar Kerri-Ann CFO | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 |
Page 10 of 17 · 323 trades